Additional file 1 of Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial

van Dijk, Bastiaan T.; Bergstra, Sytske Anne; van den Berg, J. Merlijn; Schonenberg-Meinema, Dieneke; van Suijlekom-Smit, Lisette W.A.; van Rossum, Marion A.J.; Koopman-Keemink, Yvonne; ten Cate, Rebecca; Allaart, Cornelia F.; Brinkman, Daniëlle M.C.; Hissink Muller, Petra C.E.

doi:10.6084/m9.figshare.25800995.v1

12969_2024_989_MOESM1_ESM.docx (985.33 kB)

Additional file 1 of Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial

journal contribution

posted on 2024-05-11, 04:01 authored by Bastiaan T. van Dijk, Sytske Anne Bergstra, J. Merlijn van den Berg, Dieneke Schonenberg-Meinema, Lisette W.A. van Suijlekom-Smit, Marion A.J. van Rossum, Yvonne Koopman-Keemink, Rebecca ten Cate, Cornelia F. Allaart, Daniëlle M.C. Brinkman, Petra C.E. Hissink Muller

Supplementary Material 1

Funding

Pfizer Pharmaceuticals

History

Usage metrics

Keywords

Juvenile idiopathic arthritis Etanercept Dose Treat-to-target Randomised clinical trial Efficacy Adverse events

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial

Funding

Pfizer Pharmaceuticals

History

Usage metrics

Categories

Keywords

Licence

Exports